A phase 2 study of fixed duration therapy with pirtobrutinib and obinutuzumab in previously untreated chronic lymphocytic leukemia (POP)
ANNOUNCEMENT: We no longer accept cash payments.
By using this website, you agree to the use of cookies and our privacy policy.